Related references
Note: Only part of the references are listed.Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy
Ting Zhou et al.
NATURE (2020)
A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control
Zhichen Sun et al.
NATURE COMMUNICATIONS (2019)
Cytokines in clinical cancer immunotherapy
Pedro Berraondo et al.
BRITISH JOURNAL OF CANCER (2019)
Cancer immunoediting and resistance to T cell-based immunotherapy
Jake S. O'Donnell et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy
Fernando Souza-Fonseca-Guimaraes et al.
TRENDS IN IMMUNOLOGY (2019)
First-in-Human Phase I Trial of a Tumor-Targeted Cytokine (NHS-IL12) in Subjects with Metastatic Solid Tumors
Julius Strauss et al.
CLINICAL CANCER RESEARCH (2019)
Unopposed IL-18 signaling leads to severe TLR9-induced macrophage activation syndrome in mice
Charlotte Girard-Guyonvarc'h et al.
BLOOD (2018)
Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment
Kyohei Nakamura et al.
CANCER CELL (2018)
A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments
Kevin C. Barry et al.
NATURE MEDICINE (2018)
IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity
Martina Molgora et al.
NATURE (2017)
CAR T Cells Releasing IL-18 Convert to T-Bethigh FoxO1low Effectors that Exhibit Augmented Activity against Advanced Solid Tumors
Markus Chmielewski et al.
CELL REPORTS (2017)
Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP
Marina Fabbi et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Interleukin-18 and IL-18 binding protein
Charles A. Dinarello et al.
FRONTIERS IN IMMUNOLOGY (2013)
Interleukin-18: Biology and Role in the Immunotherapy of Cancer
S. Srivastava et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Severe hepatic injury in interleukin 18 (IL-18) transgenic mice: a key role for IL-18 in regulating hepatocyte apoptosis in vivo
S Finotto et al.
GUT (2004)
NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer
MJ Smyth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Share Paper
